Abrocitinib for atopic dermatitis: a step forward

Lancet. 2020 Jul 25;396(10246):215-217. doi: 10.1016/S0140-6736(20)31284-8.

Authors

Stephan Weidinger¹, Stefan Schreiber²

Affiliations

¹ Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, 24105 Kiel, Germany; Excellence Cluster Precision Medicine in Inflammation, Kiel, Germany. Electronic address: [email protected].
² Department of Internal Medicine, University Hospital Schleswig-Holstein, 24105 Kiel, Germany; Excellence Cluster Precision Medicine in Inflammation, Kiel, Germany.

PMID: 32711781
DOI: 10.1016/S0140-6736(20)31284-8

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Kommentar

MeSH terms

Adolescent
Adult
Dermatitis, Atopic*
Double-Blind Method
Eczema*
Humans
Pyrimidines
Sulfonamides

Substances

Pyrimidines
Sulfonamides
abrocitinib